Oasis Pharmaceutical's mission is to advance novel treatments that meaningfully improve the health of patients with inflammatory, fibrotic, and metabolic disorders by targeting the G-protein coupled receptor (GPCR) Protease-activated Receptor 2 (PAR2) and other receptor targets.